WhitTier Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History

WhitTier Trust Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$247K	Buy	569 +16	+3%	+$7.46K	0.01%	470
2025 Q4	$259K	Sell	553 -104	-16%	-$44.8K	0.01%	447
2025 Q3	$265K	Buy	657 +113	+21%	+$47.2K	0.01%	437
2025 Q2	$242K	Sell	544 -8	-1%	-$3.69K	0.01%	497
2025 Q1	$268K	Buy	552 +67	+14%	+$31.2K	0.01%	481
2024 Q4	$195K	Sell	485 -91	-16%	-$42.2K	﹤0.01%	499
2024 Q3	$268K	Buy	576 +25	+5%	+$12K	0.01%	439
2024 Q2	$258K	Sell	551 -28	-5%	-$12.2K	0.01%	434
2024 Q1	$242K	Buy	579 +18	+3%	+$7.61K	0.01%	442
2023 Q4	$228K	Sell	561 -301	-35%	-$111K	0.01%	443
2023 Q3	$300K	Sell	862 -5	-0.6%	-$1.75K	0.01%	394
2023 Q2	$305K	Sell	867 -4	-0.5%	-$1.35K	0.01%	405
2023 Q1	$274K	Buy	871 +373	+75%	+$112K	0.01%	414
2022 Q4	$144K	Sell	498 -340	-41%	-$104K	0.01%	496
2022 Q3	$243K	Buy	838 +315	+60%	+$90.6K	0.01%	433
2022 Q2	$147K	Sell	523 -96	-16%	-$25.7K	0.01%	499
2022 Q1	$162K	Hold	619	–	–	0.01%	490
2021 Q4	$136K	Sell	619 -32	-5%	-$6.22K	0.01%	520
2021 Q3	$118K	Buy	651 +366	+128%	+$71.5K	﹤0.01%	525
2021 Q2	$57K	Hold	285	–	–	﹤0.01%	640
2021 Q1	$61K	Hold	285	–	–	﹤0.01%	608
2020 Q4	$67K	Hold	285	–	–	﹤0.01%	575
2020 Q3	$78K	Hold	285	–	–	﹤0.01%	538
2020 Q2	$83K	Hold	285	–	–	0.01%	507
2020 Q1	$68K	Hold	285	–	–	0.01%	516
2019 Q4	$62K	Hold	285	–	–	﹤0.01%	558
2019 Q3	$48K	Hold	285	–	–	﹤0.01%	605
2019 Q2	$52K	Hold	285	–	–	﹤0.01%	580
2019 Q1	$52K	Hold	285	–	–	﹤0.01%	581
2018 Q4	$47K	Hold	285	–	–	﹤0.01%	584
2018 Q3	$55K	Hold	285	–	–	﹤0.01%	598
2018 Q2	$48K	Hold	285	–	–	﹤0.01%	613
2018 Q1	$46K	Hold	285	–	–	﹤0.01%	626
2017 Q4	$43K	Hold	285	–	–	﹤0.01%	595
2017 Q3	$43K	Hold	285	–	–	﹤0.01%	566
2017 Q2	$37K	Hold	285	–	–	﹤0.01%	593
2017 Q1	$31K	Hold	285	–	–	﹤0.01%	618
2016 Q4	$21K	Hold	285	–	–	﹤0.01%	684
2016 Q3	$25K	Sell	285 -40	-12%	-$3.78K	﹤0.01%	652
2016 Q2	$28K	Buy	325 +40	+14%	+$3.46K	﹤0.01%	620
2016 Q1	$23K	Hold	285	–	–	﹤0.01%	663
2015 Q4	$36K	Hold	285	–	–	﹤0.01%	579
2015 Q3	$30K	Hold	285	–	–	﹤0.01%	610
2015 Q2	$35K	Hold	285	–	–	﹤0.01%	598
2015 Q1	$34K	Hold	285	–	–	﹤0.01%	603
2014 Q4	$34K	Hold	285	–	–	﹤0.01%	600
2014 Q3	$32K	Hold	285	–	–	﹤0.01%	614
2014 Q2	$27K	Hold	285	–	–	﹤0.01%	658
2014 Q1	$20K	Hold	285	–	–	﹤0.01%	738
2013 Q4	$21K	Hold	285	–	–	﹤0.01%	680
2013 Q3	$22K	Hold	285	–	–	﹤0.01%	645
2013 Q2	$23K	Buy	+285	New	+$21K	﹤0.01%	614

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

WhitTier Trust Company's VRTX Position: Q1 2026 in Review

WhitTier Trust Company increased its Vertex Pharmaceuticals (VRTX) stake by 2.9% in Q1 2026, buying an estimated $7.46K and bringing the position to 569 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #470.

WhitTier Trust Company first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $305K in Q2 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

WhitTier Trust Company held 569 shares of Vertex Pharmaceuticals worth $247K as of Q1 2026.
WhitTier Trust Company bought 16 Vertex Pharmaceuticals shares in Q1 2026, an estimated $7.46K.
Vertex Pharmaceuticals made up 0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #470 holding.
WhitTier Trust Company first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
WhitTier Trust Company's Vertex Pharmaceuticals position peaked at $305K in Q2 2023.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.